News

Through a series of cash payments and equity investments under a previously announced collaborative agreement, Vical has received $17.6 million to date of the $22.6 million total committed

Cytel said that AstraZeneca’s increased use of East also features automated data transfer between its clinical data system (CDS) and East’s trial monitoring component. By eliminating manual data

Beginning in North America and through its direct sales force, Zila now markets ViziLite Plus in all 50 states of the US, as well as Puerto Rico and

The offering is expected to close on February 19, 2009. On February 12, 2009, the last reported sales price of Geron common stock on the Nasdaq global market

Upon completion of the transaction, HeartWare’s operations will be integrated into Thoratec’s cardiovascular division and the combined company will offer a broad portfolio of approved devices and will

In addition, Kelly will build the commercial sales infrastructure required to launch the company’s solutions in the European market. Kelly joins RainDance from Helicos Biosciences where he served

CytoPharm, the company’s partner in Taiwan, will fund and conduct a clinical trial of 165 chronic hepatitis C patients in Taiwan. The patients will receive one of two

The technology generally relates to devices known as cannulae having multiple access port legs and at least one hemostatic valve which are adapted for insertion of various catheters

The Kay & McCaffrey patent was granted after examination by the Australian Patent Office with 38 claims that broadly cover methods and compositions of RNAi therapeutics, including a